Predicción y previsión de precio de Immunovant Inc (IMVT)IMVTImmunovant Inc

Alphio's IMVT stock price prediction model matches the current Immunovant Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.75 (-1.48%). The 1-week path is $27.94 (-0.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Immunovant Inc (IMVT) is currently a hold. The stock is priced at $28.41, which is significantly lower than the highest analyst price target of $62, suggesting potential upside. However, the RSI is at 41.167, indicating that the stock is nearing oversold territory but not yet there. The company has faced setbacks, including halting drug development for IMVT-1402, which has negatively impacted investor sentiment. The forward P/E ratio is currently at 0, reflecting uncertainty in future earnings, and the stock has seen a 14.68% decline over the last 20 days. Given these factors, while there is potential for recovery, the risks associated with its halted drug development and negative market sentiment suggest a cautious approach.

Immunovant Inc (IMVT) last closed at $28.1700001, losing -0.84%. These facts feed the 1-day and 1-week IMVT price prediction above.